Please login to the form below

Not currently logged in
Email:
Password:

Risperdal

This page shows the latest Risperdal news and features for those working in and with pharma, biotech and healthcare.

J&J to FDA: there really is no asbestos in Baby Powder

J&J to FDA: there really is no asbestos in Baby Powder

as claims relating to damages that plaintiffs say stem from the company’s hip replacement and vaginal mesh products, and antipsychotic drug  Risperdal (risperidone).

Latest news

  • Litigation concerns threaten to overshadow solid quarter at J&J Litigation concerns threaten to overshadow solid quarter at J&J

    Quite a lot of time on J&J’s conference call was however spent updating analysts on the litigation the company is facing on opioid medicines, talc, and antipsychotic drug Risperdal ... Meanwhile, earlier in October J&J was ordered to pay $8bn in 

  • Golden night for Saatchi & Saatchi at the PM Society Awards Golden night for Saatchi & Saatchi at the PM Society Awards

    This special award went to the Xenical 'butter' ad (2006), which surpassed Risperdal's 'house' and 'chest' (1998 and 2004), Tritace's 'whale' and 'walrus' (2002 and 2003), an Idrolax ad

  • Olysio drives J&J pharma sales Olysio drives J&J pharma sales

    There were decliners too however, with antipsychotic Risperdal Consta (risperidone) falling 13% to $284m and multiple myeloma therapy Velcade (bortezomib) nudging down nearly 4% to $389m.

  • Double win for J&J's schizophrenia franchise Double win for J&J's schizophrenia franchise

    Pharma company wins appeal against $1.2bn fine and Risperdal follow-up proves itself in trial. ... Its share of the franchise has now largely replaced by longer-acting follow-up Risperdal Consta.

  • Abilify Maintena launches in Europe Abilify Maintena launches in Europe

    It already faces competition from other depot formulations, including Johnson &Johnson's Risperdal Consta (risperidone) and fast-growing Xeplion (paliperidone) as well as Lilly's Zypadhera (olanzapine).

More from news
Approximately 2 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    year. We’re talking about the lawsuits J&J is facing claiming damages as a result of using its products, including opioid painkillers, Baby Powder talc and its schizophrenia drug Risperdal ... After. a successful appeal on the grounds that the sum was

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics